Skip to main content

Table 2 Family physicians who prescribe each drug at different times and mean prescriptions per physician

From: Adoption of new drugs by physicians: a survival analysis

 

Month since launching

         
 

2

3

6

12

24

36

 

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

Cefditoren

7

3.6 (4.2)

26

2.3 (1.9)

30

3.4 (2.8)

32

3.3 (5.7)

44

2.0 (2.2)

51

2.6 (2.8)

Duloxetine

38

1.5 (0.9)

67

2.0 (1.5)

125

2.4 (2.0)

172

3.5 (2.7)

176

5.1 (3.8)

*

*

Etoricoxib

14

1.1 (0.4)

32

1.6 (0.9)

41

1.4 (0.6)

44

1.5 (0.8)

48

1.9 (1.3)

124

3.1 (4.0)

Ezetimibe

31

2.0 (1.4)

59

2.0 (1.5)

94

2.3 (1.9)

148

2.7 (2.5)

200

4.0 (3.6)

191

4.6 (3.8)

Levocetirizine

8

1.6 (0.9)

9

1.6 (0.7)

21

1.2 (0.4)

75

2.2 (1.6)

132

2.4 (1.7)

158

3.0 (2.8)

Olmesartan

36

1.8 (1.0)

49

2.2 (1.3)

89

2.3 (1.7)

131

3.4 (3.7)

165

4.1 (4.8)

182

4.7 (5.5)

Pregabalin

14

1.3 (0.5)

31

1.7 (1.4)

80

1.8 (1.0)

137

2.3 (1.8)

181

3.7 (2.7)

198

5.1 (3.6)

Tiotropium

80

2.3 (1.6)

127

2.9 (2.4)

215

3.5 (2.6)

244

5.9 (4.0)

264

7.4 (4.9)

264

8.5 (5.4)

  1. n number of physicians. SD standard deviation.
  2. *Data of 36th month of duloxetine are no comparable due to changes in medical staff.